UBS Group’s Allarity Therapeutics ALLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.5K | Buy |
47,984
+47,684
| +15,895% | +$48.2K | ﹤0.01% | 6515 |
|
|
2025
Q1 | $281 | Buy |
+300
| New | +$281 | ﹤0.01% | 8533 |
|
|
2024
Q4 | – | Sell |
-18,452
| Closed | -$38.9K | – | 8635 |
|
|
2024
Q3 | $38.9K | Buy |
18,452
+17,078
| +1,243% | +$36K | ﹤0.01% | 5779 |
|
|
2024
Q2 | $8.78K | Buy |
1,374
+1,319
| +2,398% | +$8.43K | ﹤0.01% | 6622 |
|
|
2024
Q1 | $9.94K | Buy |
+55
| New | +$9.94K | ﹤0.01% | 6085 |
|
|
2023
Q3 | – | Sell |
-6
| Closed | -$23.9K | – | 8264 |
|
|
2023
Q2 | $23.9K | Buy |
+6
| New | +$23.9K | ﹤0.01% | 5731 |
|
|
2023
Q1 | – | Hold |
0
| – | -$11 | – | 8407 |
|
|
2022
Q4 | – | Hold |
0
| – | -$15K | – | 9379 |
|
|
2022
Q3 | – | Hold |
0
| – | -$3K | – | 6681 |
|
|
2022
Q2 | – | Hold |
0
| – | -$9K | – | 8230 |
|
|
2022
Q1 | – | Hold |
0
| – | -$1K | – | 7473 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8814 |
|